Results 11 to 20 of about 24,877 (187)

Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control alone.

PLoS ONE, 2017
PurposeTo examine the association of individual and combined indicators of diabetes control with diabetic retinopathy and diabetic macular edema.Materials and methodsIn this clinical, cross-sectional study, 613 adults with type 2 diabetes (372 any ...
Eva K Fenwick, Jing Xie, Ryan E K Man, Charumathi Sabanayagam, Lyndell Lim, Gwyn Rees, Tien Y Wong, Ecosse L Lamoureux   +7 more
doaj   +1 more source

Idiopathic thrombocytopenic purpura and its fundus features in a patient with diabetes mellitus

Indian Journal of Ophthalmology, 2020
In this case report, we present a patient with thrombocytopenia secondary to idiopathic thrombocytopenic purpura (ITP), whose fundus appearance had features of diabetic retinopathy with macular edema.
R Rajesh, Mahesh P Shanmugam, Pradeep Sagar   +2 more
doaj   +1 more source

Comparison of Aflibercept (Eylea®) with Ranibizumab (Lucentis®) in treatment of diabetic macular edema by Optical Coherence Tomography [PDF]

Egyptian Journal of Medical Research, 2022
Background: Diabetic macular edema (DME) can occur at any stage of non-proliferative and proliferative diabetic retinopathy. It is characterized by a swelling of the macular area that normally accounts for high-resolution visual acuity (VA), and DME ...
Hossam El din Khalil, Abdel Rahman Ahmed, Hassan Mahfouz Eliwa   +2 more
doaj   +1 more source

A study of therapeutic effects of 670 nm irradiation in different types of diabetic macular edema

Biomedical Photonics, 2021
The purpose of this study was to investigate the therapeutic effects of 670 nm irradiation in patients with diabetic macular edema. In several studies, positive effects of red/near-infrared irradiation showed in a range of ocular diseases such as macular
S. Ramin, M. Ahadi, A. Ebrahimi
doaj   +1 more source

Corticosteroids for diabetic macular edema

Taiwan Journal of Ophthalmology, 2019
Diabetic macular edema (DME) is a chronic condition with a multifactorial pathogenesis. Vascular endothelial growth factor (VEGF) and several inflammatory mediators are upregulated in eyes with DME. VEGF inhibitors and corticosteroids have all been used successfully in the management of DME.
Jorge Chawan-Saad, Max Wu, Andres Wu, Lihteh Wu   +3 more
openaire   +3 more sources

Enzymatic vitreolysis for the treatment of tractional diabetic macular edema

Therapeutic Advances in Ophthalmology, 2019
Background: A new approach to address focal vitreomacular adhesion in patients with diabetic macular edema may control and stabilize diabetic macular edema with fewer anti-vascular endothelial growth factor injections.
Bernardete Pessoa, João Coelho, Constança Coelho, Sílvia Monteiro, Carolina Abreu, João Figueira, Angelina Meireles, João Nuno Melo Beirão   +7 more
doaj   +1 more source

A Case of Diabetic Macular Edema with Prominent Chorioretinal Folds

Case Reports in Ophthalmology, 2017
Purpose: To report a case of diabetic macular edema with prominent chorioretinal folds. Case Report: This study involved a 55-year-old male with untreated bilateral diabetic retinopathy who had undergone cataract surgery at another clinic. Following that
Takaki Sato, Ryohsuke Kohmoto, Masanori Fukumoto, Seita Morishita, Daisaku Kimura, Kensuke Tajiri, Takatoshi Kobayashi, Teruyo Kida, Shota Kojima, Tsunehiko Ikeda   +9 more
doaj   +1 more source

Corticosteroid Treatment in Diabetic Macular Edema

Türk Oftalmoloji Dergisi, 2017
Diabetic macular edema is the most common cause of visual impairment in patients with diabetes mellitus. The pathogenesis of macular edema is complex and multifactorial.
Burcu Nurözler Tabakcı , Nurten Ünlü
doaj   +1 more source

Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy

Neural Regeneration Research, 2023
Diabetic retinopathy, characterized as a microangiopathy and neurodegenerative disease, is the leading cause of visual impairment in diabetic patients.
Lei Tang, Guo-Tong Xu, Jing-Fa Zhang
doaj   +1 more source

RANIBIZUMAB MONOTHERAPY VERSUS COMBINED RANIBIZUMAB PLUS TRIAMCINOLONE FOR TREATING DIABETIC MACULAR EDEMA; EVALUATION AFTER SINGLE INJECTION [PDF]

Basrah Journal of Surgery, 2015
Anti vascular endothelial growth factor (Anti-VEGF) have been proved to be the main treatment for DME and also steroids showed a significant role in resolution of diabetic macular edema(DME).
Fareed A AL-Laftah
doaj   +1 more source